Molecular Devices Ltd (MDCC) Introduces ScanLater Western Blot Detection System
10/16/2013 8:58:59 AM
Sunnyvale, California, October 16 2013 – Molecular Devices announced today the launch of the ScanLater™ Western Blot Detection System. The first of its kind system combines western blot membrane detection with a multimode microplate reader platform, eliminating the need to acquire a separate dedicated western blot system, saving both lab space and budget. The system is compatible with Molecular Devices’ SpectraMax® i3 and SpectraMax Paradigm® Platforms.
ScanLater System is a time-resolved fluorescence (TRF)-based western blot detection assay, an optimal detection method that reduces stray excitation light, resulting in lower background noise and higher sensitivity. The ScanLater System comprises the ScanLater Western Blot Detection Cartridge, ScanLater Western Blot Kit and image acquisition software powered by SoftMax Pro® Software. ScanLater Western Blot Kits contain europium-labeled secondary antibodies designed to work with existing primary antibodies without further optimization. This substrate-free method of western blot detection not only outperforms traditional chemiluminescence and fluorescence-based western blot detection, it also allows membrane detection at any time.
Users can add western blot detection capability to the SpectraMax i3 or SpectraMax Paradigm Platform in just minutes by installing the ScanLater Western Blot Detection Cartridge. The cartridge is driven by SoftMax Pro Software, enabling users to run both microplate-based assays and western blot membrane detection from one software platform. SoftMax Pro Software provides a simple interface for acquiring .tif based images which may be printed, saved or exported to third party analysis packages. Using an add-on for ImageJ in SoftMax Pro Software, ScanLater System images are seamlessly exported with a single click.
Kevin Chance, President at Molecular Devices, commented: “Molecular Devices is committed to developing novel applications for our microplate customers, offering them the widest range of utility possible. The addition of the ScanLater Western Blot Detection System follows the introduction of the MiniMax Imaging Cytometer earlier this year, with the SpectraMax i3 System now leading the market in terms of application breadth.”
For more information please visit: www.moleculardevices.com/westernblot
For high resolution image please email firstname.lastname@example.org
T: +44 7771 730 919
At Molecular Devices
Vice President, Global Marketing
T: +1 408 747 3514
About Molecular Devices, LLC
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.
Molecular Devices is committed to the continual development of innovative solutions for life science applications. The Company is headquartered in Silicon Valley with offices around the globe.
For more information about the complete product portfolio, visit www.moleculardevices.com
Help employers find you! Check out all the jobs and post your resume.
comments powered by